MONTREAL, June 13 /CNW Telbec/ - Haemacure Corporation (TSX : HAE), a
Montreal-based specialty bio-therapeutics company developing high-value human
plasma-derived protein products for commercialization, announced today that
Joseph Galli, Chairman and Chief Executive Officer, will present Haemacure and
give an update on the Company's major milestone achievements at the Bio
International Convention - The Global Event for Biotechnology. The
presentation will take place on Thursday, June 19th, at 1:30 pm (PDT), in Room
3, of the San Diego Convention Centre.
